THE decision to extend the concession agreement with Pharmaniaga Bhd for another 10 years represents a major blow to much needed healthcare reforms, Galen Centre for Health and Social Policy said.
Its chief executive officer Azrul Mohd Khalib stated that while the decision represented a big win for the company and good news for its shareholders, it confirmed that the Malaysian health system was vulnerable and heavily dependent on a single company.